4//SEC Filing
BERGER FRANKLIN M 4
Accession 0001104659-25-099655
CIK 0001633932other
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 12:01 PM ET
Size
5.4 KB
Accession
0001104659-25-099655
Insider Transaction Report
Form 4
ESSA Pharma Inc.EPIX
BERGER FRANKLIN M
Director
Transactions
- Disposition to Issuer
Common Shares
2025-10-09−784,404→ 0 total
Footnotes (1)
- [F1]On October 9, 2025, pursuant to that certain Business Combination Agreement, dated July 13, 2025 (as amended by the Amendment Agreement, dated September 23, 2025, the "Agreement"), by and among the Issuer, XenoTherapeutics, Inc., Xeno Acquisition Corp. ("Purchaser") and XOMA Royalty Corporation, the Purchaser acquired all of the issued and outstanding common shares of the Issuer for (i) cash consideration of approximately US$0.12 per share and (ii) one contingent value right ("CVR") for each common share entitling its holder to receive up to approximately US$0.14 per CVR and payable within specified periods following the close of the transactions contemplated by the Agreement.
Documents
Issuer
ESSA Pharma Inc.
CIK 0001633932
Entity typeother
Related Parties
1- filerCIK 0001273885
Filing Metadata
- Form type
- 4
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 12:01 PM ET
- Size
- 5.4 KB